Medical Communications

UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …

By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …

Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …

Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …

It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …

The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the …

Three years after he became “the most hated man in America” overnight for jacking up the price of life-saving HIV-related …

After a particularly jarring bout of cold weather and snow, we may just have seen off the worst of winter …

GlaxoSmithKline has suffered a sizeable blow after losing an appeal disputing that it had engaged in anti-competitive pay-to-delay tactics to …

Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …